Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boopathy Ramakrishnan

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Biochemistry|October 21, 2020
Characterization of an Antibody Recognizing the Conserved Inner Core of <i>Pseudomonas aeruginosa</i> LipopolysaccharidesStefano Elli, Anna Alekseeva, Boopathy Ramakrishnan, et al.
Kidney International|April 28, 2019
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathyJames R Myette, Toshiki Kano, Hitoshi Suzuki, et al.
Blood Cancer Journal|November 5, 2020
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivoTengteng Yu, Bharat Chaganty, Liang Lin, et al.
Cell|July 21, 2015
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant EpitopeLuke N Robinson, Kannan Tharakaraman, Kirk J Rowley, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Biochemistry|October 21, 2020
Characterization of an Antibody Recognizing the Conserved Inner Core of <i>Pseudomonas aeruginosa</i> LipopolysaccharidesStefano Elli, Anna Alekseeva, Boopathy Ramakrishnan, et al.
Kidney International|April 28, 2019
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathyJames R Myette, Toshiki Kano, Hitoshi Suzuki, et al.
Blood Cancer Journal|November 5, 2020
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivoTengteng Yu, Bharat Chaganty, Liang Lin, et al.
Cell|July 21, 2015
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant EpitopeLuke N Robinson, Kannan Tharakaraman, Kirk J Rowley, et al.
Pageof 5